|
|
| Model Number |
8888145048P |
| Medical Device Problem Codes |
Defective Component (2292); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Bacterial Infection (1735); Encephalopathy (1833); Fever (1858); Septic Shock (2068); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
| Date of Event |
07/01/2022
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
According to the reporter, the patient was admitted prior to diagnosis of clabsi, perm hd catheter was inserted and patient had been identified to have a central line associated blood stream infection (clabsi) or catheter associated infection, the type of infection the patient had was clostridioses difficile and bacteremia.The seal alert regarding recall of affected catheters was received on 7/8/2022, alert stated that the company had identified potential leaking at the hub and recalled the affected devices but it was stated that there was no report of leaking or other specific catheter issues aside from the infection.There was no leak and there was no luer adapter issue.Tego was utilized.Alcohol pad was the cleaning agent used on the device.The insertion site was treated with chloraprep (duraprep for iodine allergy) prior to product placement.There was nothing unusual observed on the device prior to use, flushing was done with no abnormalities noted and clear guard and tegos were utilized with the device.There were no defects/damages found on the product.The catheter remained in use for ongoing dialysis treatment.There was no blood loss and blood transfusion was not required.Antibiotics were given intravenously as treatment/intervention due to the event.The patient's symptoms prior to infection were: positive blood cultures, fever, septic shock, leukocytosis and persistent encephalopathy.Hospital length of stay increased due to clabsi infection.It was stated that patient's cause of death were septic shock, crrt, persistent encephalopathy with inability to demonstrate neurologic recovery¿family opted for comfort care on (b)(6) 2022 and the patient then expired same day.Autopsy was not performed.Catheter was not recognized as the source initially.Patient then died/expired with affected line in place.
|
| |
|
Additional Manufacturer Narrative
|
|
H6 patient codes - e2402 (leukocytosis, bacteremia, septic shock).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|
|
|